BRCA2 and breast cancer: Until further investigation can be completed into the specific impact of frequent and rare APC and BRCA2 variants in Arab cohorts, all patients carrying either APC or BRCA2 variants should be considered at elevated risk of CRC and breast cancer and be offered screening accordingly.